Skip to content
MMJ Gazette
  Tuesday 5 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 4, 2025Cannabis Businesses Face Tightrope Act as Rules Shift State to State August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal July 30, 2025Starting a Cannabis Business? Here’s What You Really Need to Know First July 29, 2025New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle? July 29, 2025Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate July 28, 2025Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Marijuana  Financial Experts Divided Over Potential Cannabis Investment Surge After Rescheduling
MarijuanaNews

Financial Experts Divided Over Potential Cannabis Investment Surge After Rescheduling

Lars BeckersLars Beckers—January 8, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

The cannabis industry stands at a crossroads, with rescheduling marijuana potentially acting as a pivotal moment. While some experts foresee a financial windfall, others remain unconvinced that changes to marijuana’s federal classification will bring about significant capital inflows.

The Rescheduling Debate: Optimism Meets Skepticism

The potential reclassification of marijuana from Schedule 1 to Schedule 3 under the Controlled Substances Act has sparked mixed reactions among financial analysts. For Patrick Rea, managing director of Poseidon Garden Fund, rescheduling could mark a turning point, especially if it coincides with the elimination of the tax burden imposed by Section 280E of the Internal Revenue Code.

Section 280E prevents cannabis businesses from deducting standard business expenses, which dramatically skews profitability. Rea is confident that easing this tax burden will not only improve operator margins but also reignite investor interest. “Profitability changes everything,” he remarked.

Others, like Peter Su, director of specialty banking at Hanover Bank, are less convinced. Su contends that the federal illegality of marijuana will persist, even if reclassified. He argues that banks and institutional investors may still balk at entering the space. “If they won’t finance you at Schedule 1, why would Schedule 3 change their stance?” he questioned.

Institutional Interest: A Waiting Game

Some experts believe rescheduling could bring new players into the cannabis market, particularly from industries like tobacco, alcohol, and pharmaceuticals. Deepak Anand, principal at ASDA Consultancy Services, views the potential shift as a game-changer for these sectors. “Major corporations have been wary of entering the U.S. cannabis market due to its federal classification. Rescheduling could open doors,” Anand explained.

Despite this optimism, financier Adam Stettner, CEO of FundCanna, advises caution. Stettner believes any significant inflow of capital will occur incrementally, not as a sudden wave. “This is an industry that evolves slowly. Investors won’t rush in overnight,” he stated.

Investor Sentiment: A Market in Flux

Investor psychology plays a crucial role in determining capital flows. The cannabis industry has faced harsh penalties in the stock market, with share prices plummeting by 80-90% from their peak. Mitchell Osak, president of Quanta Consulting, views this as an overreaction that could reverse with the right catalyst. “Markets can swing from irrational pessimism to optimism very quickly,” Osak noted. He added that rescheduling could act as such a catalyst, spurring a wave of new investments.

However, Dai Truong, managing director at Arlington Capital Advisors, emphasizes that investor interest hinges on concrete policy changes. Truong argues that the removal of Section 280E, combined with rescheduling, would significantly improve operators’ financial health and attract fresh capital. “We need something to get investors excited again,” he said.

Operational Challenges Remain

Even with a more favorable tax landscape, operational efficiency will still determine which cannabis businesses thrive. New York-based accountant Kelly Fairbanks warns that not all companies are poised to benefit. “280E is only part of the equation. If a business is poorly run, it won’t magically become profitable,” she pointed out.

Fairbanks’ perspective highlights the importance of sound business practices, even in a more forgiving regulatory environment.

Debt Deals Dominate the Scene

While some predict a capital influx, others believe debt financing will continue to dominate the cannabis funding landscape. Peter Su notes that debt deals currently offer double-digit returns, making them highly attractive to lenders. He doesn’t see this trend changing with rescheduling. “Debt is where the real action is,” Su observed.

This sentiment is echoed by Stettner, who predicts that lenders will remain cautious about cannabis, regardless of its classification. “Federal illegality still casts a long shadow over this industry,” he said.

The Path Ahead: Incremental Progress

The cannabis sector’s trajectory remains uncertain. While rescheduling and tax reform could pave the way for growth, experts caution against expecting immediate transformations. The industry’s maturation will likely occur in phases, influenced by regulatory developments, market conditions, and investor sentiment.

For now, cannabis businesses and investors are keeping a close eye on Washington, hoping for clarity—and a much-needed spark.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Nevada’s Titus and Minnesota’s Omar Lead the Congressional Cannabis Caucus: What’s Next?
Ohio Cannabis Sales Top $242 Million in 2024 as Industry Faces Evolving Regulations
Related posts
  • Related posts
  • More from author
Cannabis

Cannabis Businesses Face Tightrope Act as Rules Shift State to State

August 4, 20250
Cannabis

Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves

August 3, 20250
Marijuana

Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E

August 2, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Cannabis Businesses Face Tightrope Act as Rules Shift State to State
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
  • Starting a Cannabis Business? Here’s What You Really Need to Know First
  • New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle?
  • Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate
  • Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors